Initial results from the off‐label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi‐institutional experience
Sinha S, Aboulhosn J, Asnes J, Bocks M, Zahn E, Goldstein BH, Zampi J, Hellenbrand W, Salem M, Levi D. Initial results from the off‐label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi‐institutional experience. Catheterization And Cardiovascular Interventions 2018, 93: 455-463. PMID: 30537348, DOI: 10.1002/ccd.27973.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBalloon ValvuloplastyCardiac CatheterizationCardiac Surgical ProceduresChildFemaleHeart Defects, CongenitalHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMalePostoperative ComplicationsProsthesis DesignPulmonary ValvePulmonary Valve InsufficiencyRecovery of FunctionRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsTranscatheter pulmonary valve replacementRight ventricular outflow tractDysfunctional right ventricular outflow tractsSapien S3 valvePercutaneous transcatheter pulmonary valve replacementCongenital heart diseaseTricuspid valve injuryPulmonary valve replacementS3 valveSAPIEN S3Valve injuryValve replacementNative right ventricular outflow tractSerious procedural complicationsVentricular outflow tractMulti-center experienceMulti-institutional experienceOff-label useShort-term resultsAortic compressionValve embolizationPerivalvular leakProcedural deathsClinical followMajor complications